Hartman Institute for Therapeutic Organ Regeneration

Histone variant H2A.X deposition pattern serves as a functional epigenetic mark for distinguishing the developmental potentials of iPSCs.

TitleHistone variant H2A.X deposition pattern serves as a functional epigenetic mark for distinguishing the developmental potentials of iPSCs.
Publication TypeJournal Article
Year of Publication2014
AuthorsWu T, Liu Y, Wen D, Tseng Z, Tahmasian M, Zhong M, Rafii S, Stadtfeld M, Hochedlinger K, Xiao A
JournalCell Stem Cell
Volume15
Issue3
Pagination281-294
Date Published2014 Sep 04
ISSN1875-9777
KeywordsAnimals, Base Sequence, Cell Differentiation, Cell Line, Cell Lineage, Clone Cells, Embryonic Stem Cells, Epigenesis, Genetic, Female, Gene Expression Regulation, Developmental, Histones, Induced Pluripotent Stem Cells, Mice, Inbred ICR, Models, Biological, Molecular Sequence Data, Up-Regulation
Abstract

<p>For future application of induced pluripotent stem cell (iPSC) technology, the ability to assess the overall quality of iPSC clones will be an important issue. Here we show that the histone variant H2A.X is a functional marker that can distinguish the developmental potentials of mouse iPSC lines. We found that H2A.X is specifically targeted to and negatively regulates extraembryonic lineage gene expression in embryonic stem cells (ESCs) and prevents trophectoderm lineage differentiation. ESC-specific H2A.X deposition patterns are faithfully recapitulated in iPSCs that support the development of "all-iPS" animals via tetraploid complementation, the most stringent test available of iPSC quality. In contrast, iPSCs that fail to support all-iPS embryonic development show aberrant H2A.X deposition, upregulation of extraembryonic lineage genes, and a predisposition to extraembryonic differentiation. Thus, our work has highlighted an epigenetic mechanism for maintaining cell lineage commitment in ESCs and iPSCs that can be used to distinguish the quality of iPSC lines.</p>

DOI10.1016/j.stem.2014.06.004
Alternate JournalCell Stem Cell
PubMed ID25192463
Grant ListR00 CA131560 / CA / NCI NIH HHS / United States
K99/R00 CA1311560 / CA / NCI NIH HHS / United States

Weill Cornell Medicine
Hartman Institute for Therapeutic Organ Regeneration
1300 York Ave, Box 136 New York, NY 10065